comparemela.com

Latest Breaking News On - Sternir inc - Page 10 : comparemela.com

Inhibikase Therapeutics Announces $10 Million Concurrent Registered Direct Offering and Private Placement Priced at a Premium to Market Under Nasdaq Rules

Inhibikase Therapeutics Announces FDA has Lifted the Full Clinical Hold on IkT-148009 in Parkinson s Disease

Inhibikase Therapeutics Announces Dosing of First Subjects in its 501 Bioequivalence Study of IkT-001Pro

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.